Published in Heart Disease Weekly, May 2nd, 2006
Study 1: Endothelial nitric oxide synthase polymorphism is associated with the presence of coronary artery disease (CAD), and in conjunction with hyperhomocysteinemia, increased the risk of CAD severity in a Tunisian population.
Investigators writing in the journal Clinical Chemistry report, "Hyperhomocysteinemia is an independent, graded risk factor for coronary artery disease (CAD). The G894T variant of endothelial nitric oxide synthase (eNOS) was postulated to be associated with hyperhomocysteinemia and could influence individual susceptibility to CAD."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Heart Disease Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.